XANDO
DÍAZ VILLAMARÍN
DOCENTE INVITADO
![Foto de XANDO](/img/nophoto.png)
![Foto de Hospital Universitario San Cecilio](/img/noimage_org.png)
Hospital Universitario San Cecilio
Granada, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario San Cecilio (10)
2023
-
Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation
Biomedicine and Pharmacotherapy, Vol. 168
2022
-
Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients
Pharmaceutics, Vol. 14, Núm. 8
-
Pharmacogenetics of siponimod: A systematic review
Biomedicine and Pharmacotherapy, Vol. 153
2021
-
Genetic polymorphisms affecting ranibizumab response in high myopia patients
Pharmaceutics, Vol. 13, Núm. 11
-
Pharmacogenetic polymorphisms affecting bisoprolol response
Biomedicine and Pharmacotherapy, Vol. 142
2020
-
Genetic variants affecting anti-vegf drug response in polypoidal choroidal vasculopathy patients: A systematic review and meta-analysis
Genes, Vol. 11, Núm. 11, pp. 1-13
2019
-
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention
Pharmacogenomics Journal, Vol. 19, Núm. 5, pp. 438-445
-
Pharmacogenetics in the Treatment of Cardiovascular Diseases and its current progress regarding Implementation in the Clinical Routine
Genes, Vol. 10, Núm. 4
2016
-
A new pharmacogenetic algorithm to predict the most appropriate dosage of acenocoumarol for stable anticoagulation in a mixed Spanish population
PLoS ONE, Vol. 11, Núm. 3
-
Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty
Pharmacogenomics, Vol. 17, Núm. 12, pp. 1327-1338